Dermatitis News and Research

Latest Dermatitis News and Research

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Expert offers tips for coping with peak poison ivy season

Summer officially arrives at 6:07 a.m. on Thursday. And typically, the first two months of summer coincide with the height of poison ivy season.

20 Jun 2018

Researchers uncover racial differences in debilitating itchy skin condition

An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.

14 Jun 2018

Research sheds light on pathways involved in transmitting itch sensations from skin to brain

Researchers from North Carolina State University have pinpointed a particular neuropeptide associated with transmitting itch signals in mice with atopic dermatitis.

14 Jun 2018

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

6 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Poison ivy and poison oak can cause mild to severe allergic reactions

April showers might bring May flowers, but they also bring the arrival of troublesome plants such as poison ivy and poison oak that can cause mild to severe allergic reactions.

9 May 2018

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

The use of acid-suppressing medications or antibiotics in the first 6 months of infancy was associated with an increased risk for the subsequent development of allergic diseases in childhood.

2 Apr 2018

New suggests different approach to eczema treatment

Eczema affects about 17 percent of children in developed countries and is often the gateway to food allergy and asthma, initiating an "atopic march" toward broader allergic sensitization.

6 Mar 2018

Researchers uncover new cause of dry, inflamed and itchy skin in eczema patients

Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients.

27 Feb 2018

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

It takes an average of 3.5 years to diagnose celiac disease in patients who do not report gastrointestinal symptoms, a Loyola Medicine study has found.

19 Feb 2018

Intermountain Medical Center launches rooming-in program to support bonding between mothers and newborns

Mothers and babies belong together -; which is why Intermountain Medical Center in Salt Lake City has launched a rooming-in program to support early bonding between mothers and newborns.

15 Feb 2018

Vitamin A-enriched cattle fodder is the key to protect against cow's milk allergy

A real milk allergy occurs in about three to five percent of European children and more rarely in adults. The disease is different from lactose intolerance, in which a lack of the enzyme lactase results in the inability to properly break down lactose, a sugar found in milk products.

6 Feb 2018

Scientists find how potential new eczema treatment could also alleviate asthma

Scientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma

19 Jan 2018

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes skin inflammation in atopic dermatitis and the characteristic thickening of the skin.

18 Jan 2018

New yardstick offers practical recommendations for treatment of atopic dermatitis

Patients with atopic dermatitis (AD) - also known as eczema - often face a tough, uphill battle for treatment. Symptoms include severe itching, scaly rashes, extreme dry skin and inflammation.

4 Jan 2018

Asthma and allergic rhinitis linked to increased risk of cataracts

In a study that investigated the association between allergic diseases and ophthalmologic diseases in 14,776 adults, asthma and allergic rhinitis were each associated with a 50% increased likelihood of having cataracts. Atopic dermatitis was not linked with cataracts in the Journal of Dermatology study, however.

4 Jan 2018

Rutgers studies highlight need for salon clients, workers to protect themselves from health risks

Clients who frequent hair and nail salons exhibit more skin and fungal diseases than those who visit less often and nail salon technicians are receiving inadequate training in the use of chemicals, suggest two Rutgers School of Public Health studies.

14 Dec 2017

Researchers identify distinct subgroups of eczema in children

Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

22 Nov 2017

Dermatitis News and Research

Latest Dermatitis News and Research

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Expert offers tips for coping with peak poison ivy season

Researchers uncover racial differences in debilitating itchy skin condition

Research sheds light on pathways involved in transmitting itch sensations from skin to brain

Regeneron collaborates with Zoetis to research antibody therapies for animals

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Celgene to share new and updated data around novel hematological therapies

Poison ivy and poison oak can cause mild to severe allergic reactions

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

New suggests different approach to eczema treatment

Researchers uncover new cause of dry, inflamed and itchy skin in eczema patients

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

Intermountain Medical Center launches rooming-in program to support bonding between mothers and newborns

Vitamin A-enriched cattle fodder is the key to protect against cow's milk allergy

Scientists find how potential new eczema treatment could also alleviate asthma

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

New yardstick offers practical recommendations for treatment of atopic dermatitis

Asthma and allergic rhinitis linked to increased risk of cataracts

Rutgers studies highlight need for salon clients, workers to protect themselves from health risks

Researchers identify distinct subgroups of eczema in children

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Dermatitis News and Research

Latest Dermatitis News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in